Flagship platformIn development

CLAIR by MicroCD Labs

Making saliva more reliable for quantitative point-of-care research.

CLAIR is an in-development centrifugal microfluidic platform designed to standardize sample preparation, fluid handling, assay timing, and smartphone optical readout in one cartridge-led workflow.

Development boundary: CLAIR is not for sale or clinical use. Analytical performance, workflow timing, and clinical utility remain to be established for each panel.

The development problem

Saliva is easy to collect. Reliable measurement is harder.

01
Variable sample biology

Dilution, debris, viscosity, and collection conditions can change the sample before measurement begins.

02
Manual preparation

Pipetting, timing, mixing, and transfer steps introduce operator-dependent variability.

03
Uncontrolled readout

Phone position, illumination, focus, and endpoint timing can make quantitative interpretation less reproducible.

Platform architecture

A cartridge-led path from collection to structured readout.

The current engineering concept assigns sample preparation, reaction control, imaging, and interpretation to defined parts of one workflow.

Abstract concept showing a sample swab, generic centrifugal cartridge, closed reader, and smartphone result screen
Public-facing concept visual. It communicates the intended workflow without representing final hardware, internal architecture, timing, or validated performance. Select the figure to enlarge.
Abstract five-stage concept representing sample introduction, separation, mixing, controlled optical reading, and data interpretation
Abstract process visual. It intentionally omits implementable cartridge geometry and proprietary engineering details.

Initial development focus

Canine oral-health decision support research.

The first planned panel is intended to study the clinical gray zone between routine monitoring and escalation to a more comprehensive dental workup.

Candidate dimensions

  • LDHTissue activity or periodontal injury
  • MPOInflammatory activity
  • Phosphorus and pHOral chemistry context
  • Occult bloodGingival bleeding signal

These markers are candidates for product development. Panel composition, thresholds, performance, and clinical interpretation require analytical and clinical validation.

Evidence discipline

Platform foundation first. Product-specific proof next.

MicroCD Labs is translating lab-on-disc, assay, imaging, and kinetic-analysis experience into a reproducible veterinary product workflow.

Foundation informing CLAIR
  • Lab-on-disc and centrifugal microfluidic development experience
  • Assay-development and time-resolved signal-analysis research
  • Prototype, motor-control, optical-reader, and cartridge engineering work
  • Patent applications and peer-reviewed technical work
Evidence still required
  • Panel-specific analytical sensitivity, precision, and interference studies
  • Transfer repeatability across discs, readers, operators, and sites
  • Veterinary workflow validation and multi-clinic pilot evidence
  • Manufacturing process, quality-control, regulatory, and commercialization planning

Patent filing note: U.S. provisional application 64/126,200 was received August 5, 2026 for Portable Centrifugal Diagnostic Platform with Mobile-Device Optical and Kinetic Assay Analysis. A provisional filing is not an issued patent or a determination of patentability.

Build the product evidence

MicroCD Labs is preparing CLAIR for focused veterinary and technical collaboration.

We welcome non-confidential conversations with veterinary clinics, assay-development specialists, cartridge and manufacturing partners, and investors aligned with disciplined product validation.